Ligand · DT1
DT1 · 4-{[5-(cyclohexylmethoxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide
DT1, 4-{[5-(cyclohexylmethoxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide (C18 H22 N6 O3 S, 402.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- DT1
- Formula
- C18 H22 N6 O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
DT1 in 2 structures; the first of them:
- 2C6I · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT1 A1299 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 14 more
- 2C6I · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT1 A1299 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 14 more
Residues it binds most
LYS 2, ALA 2, ASP 2, GLN 2, GLU 2, GLY 2, LEU 2, PHE 2, VAL 2, ASN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.